StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report published on Tuesday morning. The firm issued a buy rating on the stock.
Mannatech Price Performance
Shares of MTEX opened at $12.44 on Tuesday. The business has a 50-day moving average of $11.30 and a 200-day moving average of $8.84. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The company has a market capitalization of $23.39 million, a price-to-earnings ratio of -15.36 and a beta of 1.04. Mannatech has a 1 year low of $6.75 and a 1 year high of $15.83.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million for the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- Stock Market Sectors: What Are They and How Many Are There?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- How to Invest in Biotech Stocks
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
